Comparison of Different Conditioning Regimens in Allogeneic Hematopoietic Stem-Cell Transplantation Shows Superiority of Total Body Irradiation-Based Regimen for Younger Patients With Acute Leukemia: A Nationwide Study

被引:8
作者
Park, Hyunkyung [1 ]
Byun, Ja Min [2 ]
Koh, Youngil [2 ]
Yoon, Sung-Soo [2 ,3 ]
Park, Hyejoo [3 ]
Lee, Jayoun [4 ]
Shin, Sang-Jin [4 ]
Youk, Jeonghwan [5 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea
[2] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
[4] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea
[5] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
Acute leukemia; Asian; Myeloablative conditioning; Nonmyeloablative conditioning; ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MATCHED UNRELATED DONORS; REDUCED-INTENSITY; INTRAVENOUS BUSULFAN; WORKING PARTY; 1ST REMISSION; BU PHARMACOKINETICS; GENE POLYMORPHISMS;
D O I
10.1016/j.clml.2019.08.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recognizing the paucity of comparative data on different conditioning regimens for hematopoietic stem-cell transplantation in Asian population, we conducted a study of 1562 patients undergoing myeloablative conditioning (MAC) and 2693 patients undergoing non-MAC (NMC). We found that (1) despite the possible selection bias, MAC is associated with decreased late-phase mortality, (2) among MAC regimens, total body irradiatione based conditioning leads to better outcomes for all acute leukemias in younger patients, and (3) antithymocyte globulin use confers benefits when added to NMC regimens without compromising survival outcomes. Background: The optimal the conditioning regimens for allogeneic hematopoietic stem-cell transplantation, especially for East Asian patients, remains unknown. Patients and Methods: We collected and analyzed clinical and survival data of 4255 patients from the Korean National Health Insurance Claims Database. Results: Between 1562 myeloablative conditioning and 2693 nonmyeloablative conditioning groups, the overall survival was not statistically different. However, in the myeloablative conditioning group, the overall survival of the total body irradiationebased regimen was better than that of chemotherapy-alone regimen (P =.005). In subgroup analysis, the superiority of the total body irradiationebased regimen was especially prominent in acute leukemia (P =.012 for acute myeloid leukemia; P =.005 for acute lymphoblastic leukemia) and for younger patients (< 50 years old vs. > 50 years old, P =.015). Conclusion: Total body irradiation combination might be the best conditioning regimen for young patients undergoing hematopoietic stem-cell transplantation for acute leukemias in Korea.
引用
收藏
页码:E605 / E615
页数:11
相关论文
共 29 条
[1]   Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients [J].
Ansari, M. ;
Huezo-Diaz, P. ;
Rezgui, M. A. ;
Marktel, S. ;
Duval, M. ;
Bittencourt, H. ;
Cappelli, B. ;
Krajinovic, M. .
BONE MARROW TRANSPLANTATION, 2016, 51 (03) :377-383
[2]   Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients [J].
Ansari, M. ;
Rezgui, M. A. ;
Theoret, Y. ;
Uppugunduri, C. R. S. ;
Mezziani, S. ;
Vachon, M-F ;
Desjean, C. ;
Rousseau, J. ;
Labuda, M. ;
Przybyla, C. ;
Duval, M. ;
Champagne, M. ;
Peters, C. ;
Bittencourt, H. ;
Krajinovic, M. .
BONE MARROW TRANSPLANTATION, 2013, 48 (07) :939-946
[3]   Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT) [J].
Aoudjhane, M ;
Labopin, M ;
Gorin, NC ;
Shimoni, A ;
Ruutu, T ;
Kolb, HJ ;
Frassoni, F ;
Boiron, JM ;
Yin, JL ;
Finke, J ;
Shouten, H ;
Blaise, D ;
Falda, M ;
Fauser, AA ;
Esteve, J ;
Polge, E ;
Slavin, S ;
Niederwieser, D ;
Nagler, A ;
Rocha, V .
LEUKEMIA, 2005, 19 (12) :2304-2312
[4]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[5]  
BLAISE D, 1992, BLOOD, V79, P2578
[6]   Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation [J].
Bredeson, Christopher ;
LeRademacher, Jennifer ;
Kato, Kazunobu ;
DiPersio, John F. ;
Agura, Edward ;
Devine, Steven M. ;
Appelbaum, Frederick R. ;
Tomblyn, Marcie R. ;
Laport, Ginna G. ;
Zhu, Xiaochun ;
McCarthy, Philip L. ;
Ho, Vincent T. ;
Cooke, Kenneth R. ;
Armstrong, Elizabeth ;
Smith, Angela ;
Rizzo, J. Douglas ;
Burkart, Jeanne M. ;
Pasquini, Marcelo C. .
BLOOD, 2013, 122 (24) :3871-3878
[7]   Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT [J].
Cahu, X. ;
Labopin, M. ;
Giebel, S. ;
Aljurf, M. ;
Kyrcz-Krzemien, S. ;
Socie, G. ;
Eder, M. ;
Bonifazi, F. ;
Bunjes, D. ;
Vigouroux, S. ;
Michallet, M. ;
Stelljes, M. ;
Zuckerman, T. ;
Finke, J. ;
Passweg, J. ;
Yakoub-Agha, I. ;
Niederwieser, D. ;
Sucak, G. ;
Sengelov, H. ;
Polge, E. ;
Nagler, A. ;
Esteve, J. ;
Mohty, M. .
BONE MARROW TRANSPLANTATION, 2016, 51 (03) :351-357
[8]   Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI [J].
Copelan, Edward A. ;
Hamilton, Betty K. ;
Avalos, Belinda ;
Ahn, Kwang Woo ;
Bolwell, Brian J. ;
Zhu, Xiaochun ;
Aljurf, Mahmoud ;
van Besien, Koen ;
Bredeson, Christopher ;
Cahn, Jean-Yves ;
Costa, Luciano J. ;
de Lima, Marcos ;
Gale, Robert Peter ;
Hale, Gregory A. ;
Halter, Joerg ;
Hamadani, Mehdi ;
Inamoto, Yoshihiro ;
Kamble, Rammurti T. ;
Litzow, Mark R. ;
Loren, Alison W. ;
Marks, David I. ;
Olavarria, Eduardo ;
Roy, Vivek ;
Sabloff, Mitchell ;
Savani, Bipin N. ;
Seftel, Matthew ;
Schouten, Harry C. ;
Ustun, Celalettin ;
Waller, Edmund K. ;
Weisdorf, Daniel J. ;
Wirk, Baldeep ;
Horowitz, Mary M. ;
Arora, Mukta ;
Szer, Jeff ;
Cortes, Jorge ;
Kalaycio, Matt E. ;
Maziarz, Richard T. ;
Saber, Wael .
BLOOD, 2013, 122 (24) :3863-3870
[9]   Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia [J].
Davies, SM ;
Ramsay, NKC ;
Klein, JP ;
Weisdorf, DJ ;
Bolwell, B ;
Cahn, JY ;
Camitta, BM ;
Gale, RP ;
Giralt, S ;
Heilmann, C ;
Henslee-Downey, PJ ;
Herzig, RH ;
Hutchinson, R ;
Keating, A ;
Lazarus, HM ;
Milone, GA ;
Neudorf, S ;
Perez, WS ;
Powles, RL ;
Prentice, HG ;
Schiller, G ;
Socié, G ;
Vowels, M ;
Wiley, J ;
Yeager, A ;
Horowitz, MM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :340-347
[10]   Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial [J].
Finke, Juergen ;
Schmoor, Claudia ;
Bethge, Wolfgang Andreas ;
Ottinger, Hellmut ;
Stelljes, Matthias ;
Volin, Liisa ;
Heim, Dominik ;
Bertz, Hartmut ;
Grishina, Olga ;
Socie, Gerard .
LANCET HAEMATOLOGY, 2017, 4 (06) :E293-E301